+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Patient-Controlled Analgesic Pumps Market By Type, By Application, By End-use, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • PDF Icon

    Report

  • May 2021
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5331390
The North America Patient-controlled Analgesic Pumps Market is expected to witness market growth of 8.9% CAGR during the forecast period (2021-2027).

A method where the patient in pain becomes empowered to relieve his/her own pain is termed as Patient-controlled analgesia (PCA). Post-surgery, patients generally use computerized pump which is integrated in PCA. It often finds usage for post-operative management. With its pain-relief technique, patients become empowered to control their own pain. PCA acts as an ideal device for those patients who are having problems in consuming medication orally. Morphine, fentanyl and hydromorphone are some of the drugs given by PCA infusion.

Sometimes, the dose is predetermined and it is possible for the patients to deliver extra doses to themselves just by pressing a button. Parents as well as nurses can easily use this device for children of 6 years or below. Higher patient satisfaction, the superior quality of recovery, less sedation, a smaller number of postoperative complications, and fewer medications (as doses are set) are some of the major benefits of PCA. However, PCA also has some demerits including nurse assistance is needed when children are aged less than 5 years, chances of underdose or overdose of medication, difficulty to incorporate in patients having a critical illness (as it could result in nausea, itching, and constipation).

The US market dominated the North America Mechanical Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $82,013.6 Thousands by 2027. The Canada market is experiencing a CAGR of 12.6% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 11.6% during (2021 - 2027).

Based on Type, the market is segmented into Electronic and Mechanical. Based on Application, the market is segmented into Oncology, Diabetes, Hematology, Gastroenterology and Others. Based on End-use, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smiths Group PLC, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, Avante Health Solutions, ICU Medical, Inc., and Ace Medical Co., Ltd.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Electronic
  • Mechanical

By Application
  • Oncology
  • Diabetes
  • Hematology
  • Gastroenterology
  • Others

By End Use
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled
  • Smiths Group PLC
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Abbott Laboratories
  • Avante Health Solutions
  • ICU Medical, Inc.
  • Ace Medical Co., Ltd.
  • Mindstrong, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Patient-Controlled Analgesic Pumps Market, by Type
1.4.2 North America Patient-Controlled Analgesic Pumps Market, by Application
1.4.3 North America Patient-Controlled Analgesic Pumps Market, by End Use
1.4.4 North America Patient-Controlled Analgesic Pumps Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements,
3.2.2 Geographical Expansions
3.2.3 Approvals & Trials
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. North America Patient-Controlled Analgesic Pumps Market by Type
4.1 North America Electronic Market by Country
4.2 North America Mechanical Market by Country
Chapter 5. North America Patient-Controlled Analgesic Pumps Market by Application
5.1 North America Oncology Market by Country
5.2 North America Diabetes Market by Country
5.3 North America Hematology Market by Country
5.4 North America Gastroenterology Market by Country
5.5 North America Other Application Market by Country
Chapter 6. North America Patient-Controlled Analgesic Pumps Market by End-use
6.1 North America Hospitals Market by Country
6.2 North America Specialty Clinics Market by Country
6.3 North America Ambulatory Surgical Centers Market by Country
6.4 North America Home Care Settings Market by Country
Chapter 7. North America Patient-Controlled Analgesic Pumps Market by Country
7.1 US Patient-Controlled Analgesic Pumps Market
7.1.1 US Patient-Controlled Analgesic Pumps Market by Type
7.1.2 US Patient-Controlled Analgesic Pumps Market by Application
7.1.3 US Patient-Controlled Analgesic Pumps Market by End-use
7.2 Canada Patient-Controlled Analgesic Pumps Market
7.2.1 Canada Patient-Controlled Analgesic Pumps Market by Type
7.2.2 Canada Patient-Controlled Analgesic Pumps Market by Application
7.2.3 Canada Patient-Controlled Analgesic Pumps Market by End-use
7.3 Mexico Patient-Controlled Analgesic Pumps Market
7.3.1 Mexico Patient-Controlled Analgesic Pumps Market by Type
7.3.2 Mexico Patient-Controlled Analgesic Pumps Market by Application
7.3.3 Mexico Patient-Controlled Analgesic Pumps Market by End-use
7.4 Rest of North America Patient-Controlled Analgesic Pumps Market
7.4.1 Rest of North America Patient-Controlled Analgesic Pumps Market by Type
7.4.2 Rest of North America Patient-Controlled Analgesic Pumps Market by Application
7.4.3 Rest of North America Patient-Controlled Analgesic Pumps Market by End-use
Chapter 8. Company Profiles
8.1 Smiths Group PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Approvals & Trials:
8.2 Fresenius SE & Co. KGaA
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 B. Braun Melsungen AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Baxter International, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.1 Recent strategies and developments:
8.4.1.1 Approvals & Trials:
8.4.1.2 Acquisition and Mergers:
8.5 Becton, Dickinson and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals & Trials:
8.5.5.2 Acquisition and Mergers:
8.6 Terumo Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals & Trials:
8.7 Abbott Laboratories
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Avante Health Solutions
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 ICU Medical, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:
8.9.2.3 Geographical Expansions:
8.10. Ace Medical Co., Ltd.
8.10.1 Company Overview

Companies Mentioned

  • Smiths Group PLC
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Abbott Laboratories
  • Avante Health Solutions
  • ICU Medical, Inc.
  • Ace Medical Co., Ltd.

Methodology

Loading
LOADING...